Genetics of hemochromatosis

Annual Review of Medicine

Volumn 50, Issue , 1999, Pages 87-98

  Cullen, L M ^a   Anderson, G J ^a   Ramm, G A ^a   Jazwinska, E C ^a   Powell, L W ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

C282Y; H63D; Hemochromatosis; Iron metabolism; Positional cloning

Indexed keywords

ASPARTIC ACID; CYSTEINE; HISTIDINE; TYROSINE;

AMINO ACID SUBSTITUTION; AUTOSOMAL RECESSIVE DISORDER; CLONING; GENETICS; HEMOCHROMATOSIS; HUMAN; IRON METABOLISM; IRON OVERLOAD; MISSENSE MUTATION; PRIORITY JOURNAL; REVIEW;

AMINO ACID SUBSTITUTION; ASPARTIC ACID; CLONING, MOLECULAR; CYSTEINE; GENES, MHC CLASS I; GENES, RECESSIVE; HEMOCHROMATOSIS; HETEROZYGOTE; HISTIDINE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HOMOZYGOTE; HUMANS; IRON; MEMBRANE PROTEINS; MUTATION, MISSENSE; TYROSINE;

EID: 0033017123     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.50.1.87     Document Type: Review

References (55)

1. 1. Edwards CQ, Griffen LM, Goldgar D, et al. 1988. Prevalence of hemochromatosis among 11065 presumably healthy blood donors. N. Engl. J. Med. 318:1355-62
2. 2. Leggett BA, Halliday JW, Brown NN, et al. 1990. Prevalence of haemochromatosis amongst asymptomatic Australians. Br. J. Haematol. 74:525-30
3. 3. Trousseau A. 1865. Glycosurie, diabete sucre. In Clinique Medicale de l'Hotel-Dieu de Paris, 2:663. Paris: Anonymous Balliere
4. 4. Troiseir M. 1871. Diabete sucred. Bull. Soc. d'Anat. Paris 44:231
5. 5. Von Recklinghausen FD. 1889. Uber Hamochromatose. Taggeblet der Versainumling Deutsch Haturforscher und Artze in Heidelberg 62:324
6. 6. Sheldon JH. 1935. Haemochromatosis. London: Oxford Univ. Press
7. 7. Simon M, Bourel M, Genetet B, Fauchet R. 1977. Demonstration of recessive transmission and early detection by family HLA typing. N. Engl. J. Med. 297:1017-21
8. 8. Jazwinska EC, Lee SC, Webb SI, et al. 1993. Localization of the hemochromatosis gene close to D6S105. Am. J. Hum. Genet. 53:347-52
9. 9. Calandro LM, Baer DM, Sensabaugh GF. 1995. Characterization of a recombinant that locates the hereditary hemochromatosis gene telomeric to HLA-F. Hum. Genet. 96:339-42
10. 10. Raha-Chowdhury R, Bowen DJ, Stone C, et al. 1995. New polymorphic microsatellite markers place the haemochromatosis gene telomeric to D6S105. Hum. Mol. Genet. 4:1869-74
11. 11. Jazwinska EC, Pyper WR, Burt MJ, et al. 1995. Haplotype analysis in Australian hemochromatosis patients: evidence for a predominant ancestral haplotype exclusively associated with hemochromatosis. Am. J. Hum. Genet. 56:428-33
12. 12. Campbell RD, Trowsdale J. 1993. Map of the human MHC. Immunol. Today 14:349-52
13. 13. Burt MJ, Smit DJ, Pyper WR, et al. 1996. A 4.5-megabase YAC contig and physical map over the hemochromatosis gene region. Genomics 33:153-58
14. 14. Feder JN, Gnirke A, Thomas W, et al. 1996. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13:399-408
15. 15. Bodmer JG, Parham P, Albert ED, Marsh SG. 1997. Putting a hold on 'HLA-H.' The WHO Nomenclature Committee for Factors of the HLA System. Nat. Genet. 15:234-35
16. 16. Mercier B, Murra C, Ferec C. 1997. Putting a hold on 'HLA-H.' Nat. Genet. 15:234
17. 17. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. 1997. Global prevalence of putative haemochromatosis mutations. J. Med. Genet. 34:275-78
18. 18. Beutler E. 1997. Genetic irony beyond haemochromatosis: clinical effects of HLA-H mutations. Lancet 349:296-97
19. 19. Sham RL, Ou CY, Cappuccio J, et al. 1997. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases. Blood Cells Mol. Dis. 23:314-20
20. 20. Crawford DH, Jazwinska EC, Cullen LM, et al. 1998. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology 114:1003-8
21. 21. Crawford DH, Halliday JW, Summers KM, et al. 1993. Concordance of iron storage in siblings with genetic hemochromatosis: evidence for a predominantly genetic effect on iron storage. Hepatology 17:833-37
22. 22. Muir WA, McLaren GD, Braun W, et al. 1984. Evidence for heterogeneity in hereditary hemochromatosis. Am. J. Med. 76:806-14
23. 23. Carella M, D'Ambrosio L, Totaro A, et al. 1997. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am. J. Hum. Genet. 60:828-32
24. 24. Borot N, Roth M, Malfroy L, et al. 1997. Mutations in the MHC class I-like candidate gene for hemochromatosis in French patients. Immunogenetics 45:320-24
25. 25. Lebron JA, Bennett MJ, Vaughn DE, et al. 1998. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 93:111-23
26. 26. Feder JN, Tsuchihashi Z, Irrinki A, et al. 1997. The hemochromatosis founder mutation in HLA-H disrupts β2-microglobulin interaction and cell surface expression. J. Biol. Chem. 272:14025-28
27. 27. Waheed A, Parkkila S, Zhou XY, et al. 1997. Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with β2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc. Natl. Acad. Sci. USA 94:12384-89
28. 28. de Sousa M, Reimao R, Lacerda R, et al. 1994. Iron overload in β2-microglobulin deficient mice. Immunol. Lett. 39:105-11
29. 29. Rothenberg BE, Voland JR. 1996. β2 knockout mice develop parenchymal iron overload: a putative role for class I genes of the major histocompatibility complex in iron metabolism. Proc. Natl. Acad. Sci. USA 93:1529-34
30. 30. Zhou XY, Tomatsu S, Fleming RE, et al. 1998. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc. Natl. Acad. Sci. USA 95:2492-97
31. 31. Brink B, Disler P, Lynch S, et al. 1976. Patterns of iron storage in dietary iron overload and idiopathic hemochromatosis. J. Lab. Clin. Med. 88:725-31
32. 32. Parkkila S, Waheed A, Britton RS, et al. 1997. Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract. Proc. Natl. Acad. Sci. USA 94:2534-39
33. 33. Anderson GJ. 1996. The control of iron absorption. J. Gastroenterol. Hepatol. 11:1030-32
34. 34. Anderson GJ, Powell LW, Halliday JW. 1990. Transferrin receptor distribution and regulation in the rat small intestine. Effect of iron stores and erythropoiesis. Gastroenterology 98:576-85
35. 35. Banerjee D, Flanagan PR, Cluett J, et al. 1986. Transferrin receptors in the human gastrointestinal tract. Relationship to body iron stores. Gastroenterology 91:861-69
36. 36. Parkkila S, Waheed A, Britton RS, et al. 1997. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc. Natl. Acad. Sci. USA 94:13198-202
37. 37. Feder JN, Penny DM, Irrinki A, et al. 1998. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc. Natl. Acad. Sci. USA 95:1472-77
38. 38. Niederau C, Fisher R, Sonnenberg A, et al. 1985. Survival and causes of death in cirrhotic and non-cirrhotic patients with primary hemochromatosis. N. Engl. J. Med. 313:1256-62
39. 39. Pietrangelo A. 1996. Metals, oxidative stress and hepatic fibrogenesis. Sem. Liv. Dis. 16:13-30
40. 40. Friedman SL. 1993. Cellular basis of hepatic fibrosis: mechanisms and treatment strategies. N. Engl. J. Med 164:1202-5
41. 41. Rockey DC. 1997. The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin and nitric oxide. Hepatology 25:2-5
42. 42. Gualdi R, Casalgrandi G, Montosi G, et al. 1994. Excess iron into hepatocytes is required for activation of collagen type I gene during experimental siderosis. Gastroenterology 107:1118-24
43. 43. Pietrangelo A, Gualdi R, Casalgrandi G, et al. 1994. Enhanced hepatic collagen type 1 mRNA expression into fat-storing cells in a rodent model of hemochromatosis. Hepatology 19:714-21
44. 44. Ramm GA, Li SCY, Li L, et al. 1995. Chronic iron overload causes in vivo activation of rat lipocytes. Am. J. Physiol. 268:G451-58
45. 45. Ramm GA, Crawford DHG, Powell LW, et al. 1997. Hepatic stellate cell activation in genetic hemochromatosis: lobular distribution, effect of increasing hepatic iron and response to phlebotomy. J. Hepatol. 26:584-92
46. 1 (I) gene expression are increased in hepatic acinar zone 1 of rats with iron overload. Am. J. Physiol. 267:G908-13
47. 1 in genetic hemochromatosis: role of oxidative stress. Hepatology 27:605-10
48. 1 (I) gene expression in human liver fat-storing cells. Biochem. Biophys. Res. Commun. 194:1044-50
49. 49. Baroni GS, D'Amrosio L, Ferretti G, et al. 1998. Fibrogenic effect of oxidative stress on rat hepatic stellate cells. Hepatology 27:720-26
50. 50. Ramm GA, Britton RS, O'Neill R, et al. 1994. Identification and characterization of a receptor for tissue ferritin on activated rat lipocytes. J. Clin. Invest. 94:9-15
51. 51. Ramm GA, Britton RS, Blaner WS, et al. 1995. Vitamin A - poor lipocytes: a novel desmin-negative lipocyte subpopulation, which can be activated to myofibroblasts. Am. J. Physiol. 269:G532-41
52. 52. Ramm GA, Britton RS, O'Neill R, et al. 1996. Rat liver ferritin selectively inhibits the expression of α-smooth muscle actin in cultured rat lipocytes. Am. J. Physiol. 270:G370-75
53. 53. Ramm GA, Piva TJ, Nair VG, et al. 1997. Role of tissue ferritin in regulation of α-smooth muscle actin expression in hepatic stellate cells via PKCζ and/or nitric oxide. Hepatology 26:A451 (Abstr.)
54. 54. Stål P, Hultcrantz R. 1993. Iron increases ethanol toxicity in rat liver. J. Hepatol. 17:108-15
55. 55. Olynyk JK, Fox ES, Stephenson AH, et al. 1994. A novel in vitro model for the study of phagocytosis of iron-loaded hepatocytes by Kupffer cells. Hepatology 20:A181 (Abstr.)